Plasma proteins and osteosarcoma risk: causal evidence from Mendelian randomization
Abstract Osteosarcoma (OS) is an exceptionally aggressive bone cancer, and the identification of blood-based biomarkers for early detection and prognosis remains a significant challenge. This study aimed to investigate the causal relationships between circulating plasma proteins and OS risk using Me...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer
2025-11-01
|
| Cyfres: | Discover Oncology |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1007/s12672-025-03932-y |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|